Restricting the use of ampicillin-sulbactam.
Zavascki
A P
AP
Sandri
A M
AM
D000151:Acinetobacter Infections / Q000188:drug therapy*; D040981:Acinetobacter baumannii / Q000187:drug effects; D000667:Ampicillin / Q000494:pharmacology* / Q000627:therapeutic use; D001938:Brazil; D003428:Cross Infection / Q000188:drug therapy* / Q000382:microbiology; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination / Q000494:pharmacology* / Q000627:therapeutic use; D017723:Drug Utilization Review; D006801:Humans; D017053:Infection Control / Q000592:standards; D013407:Sulbactam / Q000494:pharmacology* / Q000627:therapeutic use
C035444:sultamicillin; D000667:Ampicillin; D013407:Sulbactam